Hamburger

Call: 1-202-476-5000

 
Find a Doctor
 
 
Email this page Email This Page
Print this page Print This Page
 

  Join Us On:
  Follow Children's on Facebook  Facebook
  Follow Children's on Twitter  Twitter
  Watch Children's on YouTube  YouTube
 
 
     
 

Reuven Joshua Schore, MD

The Center for Cancer and Blood Disorders

Departments
Oncology

Programs
Leukemia/ Lymphoma Program
Patient and Family Support Program (Cancer and Blood Disorders)

Specialties: Acute Lymphoblastic Leukemia (ALL), Leukemia

Board CertificationsAmerican Board of Pediatrics
American Board of Pediatrics/Hematology-Oncology
National Provider Identifier1033204227
E-Mail

Service LocationsChildren's National Medical Center - Sheikh Zayed Campus for Advanced Children's Medicine
111 Michigan Avenue, NW
Washington, DC 20010
Map | Driving Directions

Phone: 202-476-5000
Biography

Reuven Schore, MD, is a pediatric oncologist and a member of the Leukemia/Lymphoma Program at Children's National Medical Center.

Dr. Schore is the vice chair for a Children's Oncology Group study investigating intravenous treatments for patients with high-risk acute lymphoblastic leukemia (ALL).
Education
TypeSchoolLocationDegreeField of StudyYears
Undergraduate Education Brooklyn College of the City University of New York Brooklyn, NYBachelor of Arts 1992 -1995
Medical School SUNY Health Science Center at Brooklyn Brooklyn, NYDoctor of Medicine 1996 -2000
Affiliations and Memberships
TitleInstitutionCommittee / SectionYears
MemberAmerican Society of Clinical Oncology2003 - 2009
MemberAmerican Society of Pediatric Hematology/Oncology2003 - 2009
MemberAmerican Society of Hematology2003 - 2009
MemberAmerican Academy of Pediatrics2000 - 2009
Research
TitleStudy NameInstitutionYears
Principal InvestigatorPilot Study of Intravenous EZN-2285 (SC-PEG E. coli L-asparaginase, IND# 100594) or Intravenous Oncaspar® in the Treatment of Patients with High-Risk Acute Lymphoblastic Leukemia Children’s Oncology Group2008 - 2009
Principal InvestigatorPhase IB Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children with NeutropeniaSchering-Plough2008 - 2009
Principal InvestigatorAn Open-Label Treatment Protocol For the Use of Voraxaze as Adjunctive Treatment for Patients Experiencing or at Risk of Methotrexate ToxicityProtherics2007 - 2009
Publications
Journal Article, Müller, L.W., Schore, R.J., Zheng, Y., Thomas, E.K., Kim, M.O., Cancelas, J.A., Gu, Y., and Williams, D.A. (2008), Rac Guanosine Triphosphatases represent a potential target in AML, Leukemia.

Conference Presentation - Poster, Schore, R.J., Zheng, Y., Williams, D.A., and Gu, Y. (2006), 8th Annual OSU Comprehensive Cancer Center Scientific Meeting, Poster session presented at the Inhibition of the Rho GTPase, Rac, differentially inhibits proliferation of AML cell lines and may serve as a novel molecular target, Columbus, OH

Conference Presentation - Poster, Schore, R.J., Zheng, Y., Williams, D.A., and Gu, Y. (2006), Fourth Annual Midwest Blood Club Meeting, Poster session presented at the Rac, a Member of the Rho GTPase Family, Is a Potential Target in AML, Lexington, KY

Conference Presentation - Poster, Schore, R.J., Zheng, Y., Williams, D.A., and Gu, Y. (2006), Pediatric Academic Society/American Society of Pediatric Hematology/Oncology Meeting, Poster session presented at the Rac, a Member of the Rho GTPase Family, Is a Potential Target in AML.” Pediatric Blood & Cancer , San Francisco, CA

Conference Presentation - Poster, Gu, Y., Alvares, A., Jasti, A.C., Jansen, M., Schore, R.J., Bean, J., Jegga, A.G., Aronow, B.J., and Williams, D.A. (2005), The 6th International Symposium and Expert Workshops on Leukemia and Lymphoma, Poster session presented at the Alteration of RhoH expression is associated with human diffuse large-B-cell lymphoma, Amsterdam, Netherlands

Conference Presentation - Poster, Schore, R.J., Zheng, Y., Williams, D.A., and Gu, Y. (2005), American Society of Hematology Annual Meeting, Poster session presented at the Inhibition of the Rho GTPase, Rac, differentially inhibits proliferation of AML cell lines and may serve as a novel molecular target, Atlanta, GA


For a more comprehensive list of publications for Reuven Schore, MD view the National Library of Medicine’s PubMed online database
 


   
Feedback Form